ONO PHARMACEUTICAL CO., LTD. Logo

ONO PHARMACEUTICAL CO., LTD.

A pharmaceutical company focused on R&D in oncology, immunology, and neurology.

4528 | T

Overview

Corporate Details

ISIN(s):
JP3197600004
LEI:
Country:
Japan
Address:
大阪市中央区道修町二丁目1番5号

Description

Ono Pharmaceutical Co., Ltd. is a research and development-oriented pharmaceutical company dedicated to discovering and developing innovative medicines. With a history spanning over 300 years since its founding in 1717, the company focuses on addressing unmet medical needs for patients worldwide. Its primary research and development areas are oncology, immunology, and neurology. Ono Pharmaceutical is committed to creating unique, first-in-class drugs and is particularly recognized for its pioneering work in the field of immuno-oncology. The company's portfolio consists of prescription pharmaceuticals aimed at treating a range of diseases and conditions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2022-11-04 01:00
四半期報告書-第75期第2四半期(令和4年7月1日-令和4年9月30日)
Japanese 333.9 KB
2022-11-04 01:00
確認書
Japanese 9.2 KB
2022-08-05 02:02
確認書
Japanese 9.2 KB
2022-08-05 02:02
四半期報告書-第75期第1四半期(令和4年4月1日-令和4年6月30日)
Japanese 290.9 KB
2022-06-24 02:01
内部統制報告書-第74期(令和3年4月1日-令和4年3月31日)
Japanese 24.4 KB
2022-06-24 02:00
確認書
Japanese 9.2 KB
2022-06-24 02:00
有価証券報告書-第74期(令和3年4月1日-令和4年3月31日)
Japanese 1.7 MB
2022-02-04 01:00
四半期報告書-第74期第3四半期(令和3年10月1日-令和3年12月31日)
Japanese 356.1 KB
2021-11-05 01:06
四半期報告書-第74期第2四半期(令和3年7月1日-令和3年9月30日)
Japanese 339.1 KB
2021-08-06 02:00
四半期報告書-第74期第1四半期(令和3年4月1日-令和3年6月30日)
Japanese 294.8 KB
2021-06-18 02:04
確認書
Japanese 9.2 KB
2021-06-18 02:02
内部統制報告書-第73期(令和2年4月1日-令和3年3月31日)
Japanese 24.3 KB
2021-06-18 02:01
有価証券報告書-第73期(令和2年4月1日-令和3年3月31日)
Japanese 1.6 MB
2021-02-12 01:01
四半期報告書-第73期第3四半期(令和2年10月1日-令和2年12月31日)
Japanese 351.5 KB
2020-11-06 01:00
四半期報告書-第73期第2四半期(令和2年7月1日-令和2年9月30日)
Japanese 345.2 KB

Automate Your Workflow. Get a real-time feed of all ONO PHARMACEUTICAL CO., LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ONO PHARMACEUTICAL CO., LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for ONO PHARMACEUTICAL CO., LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.